Get access

Denosumab for the treatment and prevention of postmenopausal osteoporosis

  • Protocol
  • Intervention

Authors

  • Timothy G Bennett,

    Corresponding author
    1. Melbourne Health, Royal Melbourne Hospital, Department of Rheumatology, Melbourne, Victoria, Australia
    • Timothy G Bennett, Department of Rheumatology, Melbourne Health, Royal Melbourne Hospital, Grattan Street, Parkville, Melbourne, Victoria, 3050, Australia. Timothy.Bennett@mh.org.au.

    Search for more papers by this author
  • Kim Le Marshall,

    1. Austin Health, Department of Rheumatology, Melbourne, Victoria, Australia
    Search for more papers by this author
  • Fary Khan,

    1. Royal Melbourne Hospital, Royal Park Campus, Department of Rehabilitation Medicine, Melbourne, Victoria, Australia
    Search for more papers by this author
  • John D Wark,

    1. University of Melbourne and Royal Melbourne Hospital, Department of Medicine, Melbourne, Victoria, Australia
    Search for more papers by this author
  • Caroline Brand

    1. Monash University, Centre of Research Excellence in Patient Safety (CREPS), Department of Epidemiology & Preventive Medicine, Melbourne, Victoria, Australia
    2. The University of Melbourne and Melbourne Health, Department of Clinical Epidemiology, Biostatistics and Health Services Research, Department of Medicine, Melbourne, Victoria, Australia
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the clinical efficacy and safety of denosumab in the prevention and treatment of osteoporosis compared to placebo or active comparator in postmenopausal women.